Systems and methods for failure mode detection in process chromatography

US12025599B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12025599-B2
Application numberUS-202217953818-A
CountryUS
Kind codeB2
Filing dateSep 27, 2022
Priority dateFeb 15, 2018
Publication dateJul 2, 2024
Grant dateJul 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.

First claim

Opening claim text (preview).

What is claimed: 1. A method for detecting a column malfunction in a chromatography process, comprising: (a) contacting a reference sample comprising a plurality of analytes and a VEGF-Trap protein with a chromatography column comprising a separation composition comprising a matrix, under conditions sufficient for the VEGF-Trap protein to reversibly bind to and be eluted from the matrix upon contacting the matrix with an elution composition, whereby generating a reference chromatogram from the chromatography column by plotting an absorbance value of at least a first waste composition, a second waste composition and an eluted analyte composition as a function of volume of liquid that traverses the chromatography column, wherein the plotting occurs continuously as the compositions exit the chromatography column; (b) contacting a process sample comprising the plurality of analytes and the VEGF-Trap protein with a chromatography column comprising a separation composition comprising a matrix, under conditions sufficient for the VEGF-Trap protein to reversibly bind to and be eluted from the matrix upon contacting the matrix with the elution composition, whereby generating a process chromatogram from the chromatography column by plotting an absorbance value of at least a first waste composition as a function of volume of liquid that traverses the chromatography column, wherein the plotting occurs continuously as the composition exits the chromatography column; (c) comparing the process chromatogram to the reference chromatogram thereby detecting an atypical profile in the process chromatogram, wherein the atypical profile comprises one or more features which indicate the column malfunction selected from the group consisting of: (i) an additional peak on the process chromatogram when compared to a comparable position on the reference chromatogram, and (ii) a measured absorbance intensity exceeding a maximum absorbance intensity during an integral volume window, wherein the one or more features which indicate the column malfunction occur prior to the step of contacting the chromatography column with the elution composition; (d) generating a warning signal when the atypical profile is detected; and (e) halting the chromatography process when the atypical profile is detected and until the column malfunction is resolved. 2. The method of claim 1 , wherein the chromatography process comprises ion exchange chromatography. 3. The method of claim 1 , wherein the chromatography process comprises affinity chromatography. 4. The method of claim 1 , wherein the chromatography process comprises hydrophobic interaction chromatography. 5. The method of claim 1 , wherein the column malfunction is caused by column deterioration. 6. The method of claim 5 , wherein the column deterioration comprises column bed fracturing. 7. The method of claim 1 , wherein the additional peak occurs during a washing step in the chromatography process. 8. The method of claim 1 , wherein the magnitude of the additional peak indicates a degree of severity of the column malfunction. 9. The method of claim 8 , wherein an increase in the magnitude of the additional peak indicates an increase in the degree of severity of the column malfunction of the chromatography process. 10. The method of claim 1 , wherein the column malfunction induces a loss of separation power of the chromatography column. 11. The method of claim 1 , wherein the measured absorbance intensity is determined at a wavelength corresponding to ultraviolet (UV) light. 12. The method of claim 11 , wherein the measured absorbance intensity is determined at a wavelength of between 260 nanometers (nm) and 280 nm, inclusive of the endpoints. 13. The method of claim 11 , wherein the measured absorbance intensity is determined at a wavelength of 260 nm, providing an A 260 value. 14. The method of claim 11 , wherein the measured absorbance intensity is determined at a wavelength of 280 nm, providing an A 280 value. 15. The method of claim 11 , wherein the maximum absorbance intensity has an A 260 value or an A 280 value of at least 0.05. 16. The method of claim 1 , wherein the reference chromatogram comprises a measured absorbance intensity that does not exceed a maximum absorbance intensity during an integral volume window and wherein the maximum absorbance intensity has an A 260 value or an A 280 value of 0.05 or less. 17. The method of claim 1 , wherein the integral volume window occurs between 1000 L and 2500 L, inclusive of the endpoints. 18. The method of claim 1 , wherein the integral volume window occurs between 1250 L and 2250 L, inclusive of the endpoints. 19. The method of claim 1 , wherein the integral volume window occurs between 1600 L and 1800 L, inclusive of the endpoints. 20. The method of claim 1 , wherein the chromatography column comprises an anion exchange resin. 21. The method of claim 1 , wherein the step of (a) generating the reference chromatogram comprises: (1) binding the VEGF-Trap protein to the matrix, to produce a VEGF-Trap protein bound column and a first waste composition; (2) contacting the VEGF-Trap protein bound column of (1) and a washing composition, wherein the VEGF-Trap protein remains bound to the matrix to produce a purified VEGF-Trap protein bound column and a second waste composition; (3) contacting the purified VEGF-Trap protein bound column of (2) and an elution composition, wherein the VEGF-Trap protein is released from the matrix into the elution composition to produce an eluted VEGF-Trap protein composition; (4) collecting the eluted VEGF-Trap protein composition; (5) simultaneously with each of steps (1)-(4), contacting each of the first waste composition, the second waste composition, and the eluted VEGF-Trap protein composition with ultraviolet (UV) light, (6) measuring an absorbance of the UV light of each of the first waste composition, the second waste composition, and the eluted VEGF-Trap protein composition to produce an absorbance value for each of the first waste composition, the second waste composition, and the eluted VEGF-Trap protein composition; and (7) generating a chromatogram by plotting the absorbance value of each of the first waste composition, the second waste composition, and the eluted VEGF-Trap protein composition as a function of volume of liquid that traverses the chromatography column. 22. The method of claim 21 , wherein the contacting step (5) and the measuring step (6) are continuous. 23. The method of claim 1 , wherein the step of (b) generating the process chromatogram comprises: (1) binding the VEGF-Trap protein to the matrix, to produce a VEGF-Trap protein bound column and a first waste composition; (2) contacting the VEGF-Trap protein bound column of (1) and a washing composition, wherein the VEGF-Trap protein remains bound to the matrix to produce a purified VEGF-Trap protein bound column and a second waste composition; (3) contacting the purified VEGF-Trap protein bound column of (2) and an elution composition, wherein the VEGF-Trap protein is released from the matrix into the elution composition to produce an eluted VEGF-Trap protein composition; (4) collecting the eluted VEGF-Trap protein composition; (5) simultaneously with each of steps (1)-(4), contacting each of the first waste composition, the second waste composition, and the eluted VEGF-Trap protein composition with ultraviolet (UV) light, (6) measuring an absorbance of the UV light

Assignees

Inventors

Classifications

  • C07K14/475Primary

    Growth factors; Growth regulators · CPC title

  • monitoring the quality of the stationary phase; column performance · CPC title

  • with hydrophobic interaction · CPC title

  • packing · CPC title

  • by chromatography · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12025599B2 cover?
The disclosure provides systems and methods useful for predicting or detecting a malfunction in a chromatography process in real-time. In some embodiments, the disclosure provides systems and methods for detecting an atypical profile in a process chromatogram in ion-exchange chromatography of a biologic product.
Who is the assignee on this patent?
Regeneron Pharma
What technology area does this patent fall under?
Primary CPC classification C07K14/475. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).